| [1] | JEMAL A,BRAY F,CENTER MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69. |
| [2] | KIM DY,HAN KH.Epidemiology and surveillance of hepatocellular carcinoma[J].Liver cancer,2012,1(1):2. |
| [3] | LENCIONI R,CHEN XP,DAGHER L,et al.Treatment of intermediate/advanced hepatocellular carcinoma in the clinic:how can outcomes be improved?[J].Oncologist,2010,15(Suppl 4):42. |
| [4] | FORNER A,REIG ME,DE LOPE CR,et al.Current strategy for staging and treatment:the BCLC update and future prospects[J].Semin Liver Dis,2010,30(1):61. |
| [5] | LEUNG TW,TANG AM,ZEE B,et al.Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system,the Okuda staging system,and the Cancer of the Liver Italian Program staging system:a study based on 926 patients[J].Cancer,2002,94(6):1760. |
| [6] | LIN CY,KEE KM,WANG JH,et al.Is the Cancer of the Liver Italian Program system an adequate weighting for survival of hepatocellular carcinoma evaluation of intrascore prognostic value among 36 subgroups[J].Liver Int,2009,29(1):74. |
| [7] | CILLO U,VITALE A,GRIGOLETTO F,et al.Prospective validation of the Barcelona Clinic Liver Cancer staging system[J].J Hepatol,2006,44(4):723. |
| [8] | CILLO U,BASSANELLO M,VITALE A,et al.The critical issue of hepatocellular carcinoma prognostic classification:which is the best tool available?[J].J Hepatol,2004,40(1):124. |
| [9] | MARRERO JA,FONTANA RJ,BARRAT A,et al.Prognosis of hepatocellular carcinoma:comparison of 7 staging systems in an American cohort[J].Hepatology,2005,41(4):707. |
| [10] | BRUIX J,SHERMAN M.Management of hepatocellular carcinoma:an update[J].Hepatology,2011,53(3):1020. |
| [11] | DE LOPE CR,TREMOSINI S,FORNER A,et al.Management of HCC[J].J Hepatol,2012,56(Suppl 1):S75. |
| [12] | BOLONDI L,BURROUGHS A,DUFOUR JF,et al.Heterogeneity of patients with intermediate(BCLC B) Hepatocellular Carcinoma:proposal for a subclassification to facilitate treatment decisions[J].Semin Liver Dis,2012,32(4):348. |
| [13] | SCAFFARO LA,STELLA SF,ALVARES-DA-SILVA MR,et al.Survival rates according to barcelona clinic liver cancer sub-staging system after transarterial embolization for intermediate hepatocellular carcinoma[J].World J Hepatol,2015,7(3):628. |
| [14] | CIRIA R,LOPEZ-CILLERO P,GALLARDO AB,et al.Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma:Modern surgical resection as a feasible alternative to transarterial chemoemolization[J].Eur J Surg Oncol,2015,41(9):1153. |
| [15] | LLOVET JM,JOSEP F,JORDI B,et al.The Barcelona approach:diagnosis,staging,and treatment of hepatocellular carcinoma[J].Liver Transpl,2004,10(2 Suppl 1):S115. |
| [16] | KIM BK,KIM SU,PARK JY,et al.Applicability of BCLC stage for prognostic stratification in comparison with other staging systems:single centre experience from long-term clinical outcomes of 1717 treatment-naive patients with hepatocellular carcinoma[J].Liver Int,2012,32(7):1120. |